A leading European provider of private equity with a 25-year track record of buying established businesses and working with management to create and release value within companies across Europe.
European private equity firm Bridgepoint has appointed Charles Barter as its general counsel. Mr Barter, who was head of the private equity group of UK law firm Travers Smith, will join Bridgepoint in October 2008.
Barbara Kux and Dr Hubertus Erlen have been appointed to the European Advisory Committee of private equity firm Bridgepoint.
European private equity firm Bridgepoint today announced that it had promoted six directors within its investment team to the partnership.
Charterhouse Capital Partners has agreed to acquire Tunstall Group, the European market leader in telecare systems for the elderly and infirm, from Bridgepoint in a transaction totalling £514 million.
UK engineering group Concentric has been sold by Bridgepoint to Haldex of Sweden, a quoted provider of innovative technology solutions to the global vehicle industry, for an undisclosed sum.
European private equity firm Bridgepoint has agreed to acquire a majority stake in Pret A Manger, the UK's leading retailer of good, natural, ready-to-eat sandwiches, salads and drinks.
Mid-market buyouts fuel industry growth. Highest rise in the value of UK buyouts in the past five years.
CTL Logistics, Central Europe's leading private rail logistics company and one of the largest private rail operators in Europe, has been acquired by Bridgepoint for an undisclosed sum.
Alliance Medical, a leading provider of diagnostic imaging services to the European healthcare sector, has been sold by Bridgepoint to Dubai International Capital for £600 million.
J. Frank Brown, Dean of leading international business school INSEAD, has been appointed to Bridgepoint's European Advisory Committee.
Through a combination of financial, industrial and strategic skills, we identify and acquire European businesses valued up to €1 billion where significant value can be created. View our current investments.